Nuclear receptor E75/NR1D2 drives tumor malignant transformation by integrating Hippo and Notch pathways
X. Wang, Y. Guo, P. Lin, M. Yu, S. Song, W. Xu, D. Kong, Y. Wang, Y. Zhang, F. Lu, Q. Xie, X. Ma
The paper shows that E75/NR1D2 integrates Hippo and Notch pathways to drive tumor malignancy in response to hormone inhibition.
bioRxiv · Jun 27, 2024 · PreprintCancer Biology